Skip to content

The retrospective study of risk factors of Medication related osteonecrosis of the jaw (MRONJ) after oral surgery

The retrospective study of risk factors of Medication related osteonecrosis of the jaw (MRONJ) after oral surgery - The study of risk factors of MRONJ after oral surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000021543
Enrollment
600
Registered
2016-04-01
Start date
2016-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication related osteonecrosis of the jaw

Interventions

None listed

Sponsors

Kobe University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The subjects is the patients with bisphosphonate drug or anti-RANKL monoclonal antibody drug receiving oral surgery at the Department of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine and the institutions of research collaboration.

Exclusion criteria

Exclusion criteria: Patients who principal investigator has determined to be inappropriate as a subject.

Design outcomes

Primary

MeasureTime frame
The presence or absence of MRONJ

Countries

Japan

Contacts

Public ContactTakumi Hasegawa

Kobe University Graduate School of Medicine Department of Oral and Maxillofacial Surgery

hasetaku@med.kobe-u.ac.jp078-382-6213

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026